Tengion Inc.

(TNGNQ)

By |

Profile

Tengion Inc is a regenerative medicine company. The Company is engaged in discovering, manufacturing and commercializing neo-organs, or products composed of living cells, with or without synthetic or natural materials.

Contact Information

Website: www.tengion.com
Main Phone: +1 336 722-5855
Address: 3929 Westpoint Boulevard
Address 2: Suite G
State: NC
City / Town: Winston-Salem
Country: USA
Postal Code: 27103

Issuer Information

Exchange: OTO
Employees: 27
NAICS: Pharmaceutical P
$ 0.00 ($ 0.00) (-12.50%)
Last Price 0.00 Change $ -0.00 Change % -12.50 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open 0.00 High 0.00 Low 0.00 Prev Close 0.00
Last Trade Volume 111,504 52 Wk Hi 0.00 52 Wk Low 0.00
Market Cap 28,172 Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 40,245,124.00 EPS (TTM) -0.92 PE Ratio N/A Exchange OTCPK
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 7.5 7.5 7.5 7.5
Low Target Price Estimate 7.5 7.5 7.5 7.5
Mean Target Price Estimate 7.5 7.5 7.5 7.5
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 06/20/12 06/20/12 06/20/12 06/20/12
Form Type Form Description Pages Date
SC 13G/A Amendment to the SC 13G filing 13 2016-02-16
SC 13G/A Amendment to the SC 13G filing 7 2016-02-12
SC 13G Statement of beneficial ownership of common stock by certain persons 9 2015-10-02
SC 13G/A Amendment to the SC 13G filing 9 2015-02-18
SC 13G/A Amendment to the SC 13G filing 8 2015-02-17
SC 13G/A Amendment to the SC 13G filing 13 2015-02-17
SC 13G/A Amendment to the SC 13G filing 5 2015-02-13
SC 13G/A Amendment to the SC 13G filing 7 2015-02-13
SC 13D/A Amendment to a SC 13D filing 8 2015-02-11
SC 13G/A Amendment to the SC 13G filing 5 2015-02-11
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 0 0 0 1

News